Jinling Pharmaceutical Co Ltd (000919) — Capital Reinvestment Ratio
Latest as of September 2025:
0.17x
Jinling Pharmaceutical Co Ltd (000919) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥74.01 Million) in capital expenditures (CN¥12.56 Million). See Jinling Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.17x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥74.01 Million
CNY
Capital Expenditures
CN¥12.56 Million
CNY
Data as of
Sep 2025
Most recent filing
Jinling Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2024)
This chart tracks Jinling Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 26 annual periods.
Annual Capital Reinvestment Ratio for Jinling Pharmaceutical Co Ltd (1999–2024)
Year-by-year Capital Reinvestment Ratio for Jinling Pharmaceutical Co Ltd from 1999 to 2024. For live market cap and broader valuation context, see 000919 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.31x | CN¥154.19 Million | CN¥201.63 Million | ▲ +11.6% |
| 2023 | 1.17x | CN¥158.92 Million | CN¥186.25 Million | ▼ -1.4% |
| 2022 | 1.19x | CN¥260.59 Million | CN¥309.64 Million | ▲ +113.2% |
| 2021 | 0.56x | CN¥292.03 Million | CN¥162.76 Million | ▼ -40.4% |
| 2020 | 0.94x | CN¥311.46 Million | CN¥291.41 Million | ▲ +246.7% |
| 2019 | 0.27x | CN¥465.85 Million | CN¥125.71 Million | ▼ -14.2% |
| 2018 | 0.31x | CN¥433.83 Million | CN¥136.42 Million | ▲ +108.6% |
| 2017 | 0.15x | CN¥443.11 Million | CN¥66.80 Million | ▼ -86.5% |
| 2016 | 1.12x | CN¥96.15 Million | CN¥107.45 Million | ▲ +127.6% |
| 2015 | 0.49x | CN¥212.45 Million | CN¥104.31 Million | ▲ +61.6% |
| 2014 | 0.30x | CN¥299.89 Million | CN¥91.14 Million | ▼ -42.8% |
| 2013 | 0.53x | CN¥271.21 Million | CN¥144.05 Million | ▼ -34.7% |
| 2012 | 0.81x | CN¥232.12 Million | CN¥188.76 Million | ▲ +71.0% |
| 2011 | 0.48x | CN¥172.82 Million | CN¥82.20 Million | ▼ -11.4% |
| 2010 | 0.54x | CN¥177.81 Million | CN¥95.48 Million | ▲ +4.7% |
| 2009 | 0.51x | CN¥188.41 Million | CN¥96.60 Million | ▲ +607.8% |
| 2008 | 0.07x | CN¥305.26 Million | CN¥22.11 Million | ▼ -59.2% |
| 2007 | 0.18x | CN¥118.06 Million | CN¥20.97 Million | ▲ +6.5% |
| 2006 | 0.17x | CN¥138.50 Million | CN¥23.09 Million | ▼ -50.2% |
| 2005 | 0.33x | CN¥109.29 Million | CN¥36.61 Million | ▼ -26.1% |
| 2004 | 0.45x | CN¥159.81 Million | CN¥72.47 Million | ▲ +29.4% |
| 2003 | 0.35x | CN¥161.86 Million | CN¥56.73 Million | ▼ -55.5% |
| 2002 | 0.79x | CN¥130.36 Million | CN¥102.63 Million | ▼ -54.6% |
| 2001 | 1.73x | CN¥92.49 Million | CN¥160.27 Million | ▲ +198.0% |
| 2000 | 0.58x | CN¥231.31 Million | CN¥134.49 Million | ▼ -67.7% |
| 1999 | 1.80x | CN¥39.77 Million | CN¥71.57 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow